"House Rules" for Innovative Therapy in Multiple Myeloma: Guidance on Integrating Monoclonal Antibodies and BCMA and Non-BCMA Options Into Patient Care
•Als PPT, PDF herunterladen•
0 gefällt mir•62 views
Chair, Robert Z. Orlowski, MD, PhD, Suzanne Lentzsch, MD, PhD, Krina Patel, MD, MSc, and Jeffrey A. Zonder, MD, discuss multiple myeloma in this CME activity titled “‘House Rules’ for Innovative Therapy in Multiple Myeloma: Guidance on Integrating Monoclonal Antibodies and BCMA and Non-BCMA Options Into Patient Care.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3ssatYG. CME credit will be available until March 13, 2024.
